BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19653332)

  • 21. Health-related quality of life of hematopoietic stem cell transplant childhood survivors: state of the science.
    Tanzi EM
    J Pediatr Oncol Nurs; 2011; 28(4):191-202. PubMed ID: 21636827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Díaz-Heredia C; Badell I; Bureo E; Gómez P; Martínez A; Verdeguer A; Pérez-Hurtado JM; Fernández-Delgado R; González-Vicent M; Maldonado MS
    Pediatr Hematol Oncol; 2009; 26(5):345-55. PubMed ID: 19579081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch.
    Nakai K; Mineishi S; Kami M; Kanda Y; Tanosaki R; Takaue Y
    Haematologica; 2003 Jan; 88(1):115-7. PubMed ID: 12551837
    [No Abstract]   [Full Text] [Related]  

  • 24. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.
    Hjermstad MJ; Evensen SA; Kvaløy SO; Loge JH; Fayers PM; Kaasa S
    Psychooncology; 2003 Dec; 12(8):803-13. PubMed ID: 14681953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study.
    Hwang JP; Roundtree AK; Giralt SA; Suarez-Almazor M
    BMJ Support Palliat Care; 2012 Dec; 2(4):344-50. PubMed ID: 24654219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine screening for psychosocial distress following hematopoietic stem cell transplantation.
    Lee SJ; Loberiza FR; Antin JH; Kirkpatrick T; Prokop L; Alyea EP; Cutler C; Ho VT; Richardson PG; Schlossman RL; Fisher DC; Logan B; Soiffer RJ
    Bone Marrow Transplant; 2005 Jan; 35(1):77-83. PubMed ID: 15502851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.
    Bevans MF; Mitchell SA; Barrett AJ; Bishop M; Childs R; Fowler D; Krumlauf M; Prince P; Shelburne N; Wehrlen L
    Health Qual Life Outcomes; 2011 Apr; 9():24. PubMed ID: 21496339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The outcomes of visualization and acupuncture on the quality of life of adult cancer patients receiving chemotherapy.
    Sawada NO; Zago MM; Galvão CM; Cardozo FM; Zandonai AP; Okino L; Nicolussi AC
    Cancer Nurs; 2010; 33(5):E21-8. PubMed ID: 20562622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial to improve the quality of life of type 2 diabetic patients using a self-help group program.
    Chaveepojnkamjorn W; Pichainarong N; Schelp FP; Mahaweerawat U
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):169-76. PubMed ID: 19323050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
    Worel N; Biener D; Kalhs P; Mitterbauer M; Keil F; Schulenburg A; Höcker P; Dieckmann K; Fischer G; Rosenmayr A; Linkesch W; Hinterberger W; Lechner K; Greinix HT
    Bone Marrow Transplant; 2002 Nov; 30(9):619-26. PubMed ID: 12407437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an ongoing psychoeducational inflammatory bowel disease support group in an adult outpatient setting.
    McMaster K; Aguinaldo L; Parekh NK
    Gastroenterol Nurs; 2012; 35(6):383-90. PubMed ID: 23207781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
    Reynolds C; Ratanatharathorn V; Adams P; Braun T; Silver S; Ayash L; Carson E; Eisbruch A; Dawson LA; McDonagh K; Ferrara J; Uberti J
    Bone Marrow Transplant; 2001 Apr; 27(8):801-7. PubMed ID: 11477436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection.
    Mossad S; Kalaycio M; Sobecks R; Pohlman B; Andresen S; Avery R; Rybicki L; Jarvis J; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(4):375-81. PubMed ID: 15640827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life and psychosocial sequelae in children undergoing hematopoietic stem-cell transplantation: a review.
    Tremolada M; Bonichini S; Pillon M; Messina C; Carli M
    Pediatr Transplant; 2009 Dec; 13(8):955-70. PubMed ID: 19515079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study.
    Yoon SR; Lee YS; Yang SH; Ahn KH; Lee JH; Lee JH; Kim DY; Kang YA; Jeon M; Seol M; Ryu SG; Chung JW; Choi I; Lee KH
    Bone Marrow Transplant; 2010 Jun; 45(6):1038-46. PubMed ID: 19881555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Second transplantation for graft failure after allogeneic hematopoietic stem cell transplantation--a retrospective survey by Kanto Study Group for Cell Therapy].
    Hagihara M; Kanamori H; Sakai M; Mori T; Nakaseko C; Aotsuka N; Uehara T; Sakura T; Yoshiba F; Kawai N; Tanaka M; Fujisawa S; Ohwada C; Wakita H; Yokota A; Kawamura T; Maruta A; Sakamaki H; Okamoto S;
    Rinsho Ketsueki; 2010 Jun; 51(6):390-7. PubMed ID: 20622484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life in adult patients after stem cell transplantation.
    Yano K; Kanie T; Okamoto S; Kojima H; Yoshida T; Maruta I; Dohi H; Morishita Y; Ozawa K; Sao H; Sakamaki H; Hiraoka S; Imoto S; Morishima Y; Kodera Y
    Int J Hematol; 2000 Apr; 71(3):283-9. PubMed ID: 10846837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.